<DOC>
	<DOCNO>NCT00609518</DOCNO>
	<brief_summary>Chemotherapy patient non-squamous non-small cell lung cancer . Patients give folic acid , vitamin B12 steroid , treatment , reduce side effect associate pemetrexed . The aim whether possible simplify folic acid steroid schedule without increase toxicity .</brief_summary>
	<brief_title>A Study Patients With Non-Squamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Histologic cytologic diagnosis nonsmall cell lung cancer ( NSCLC ) locally advanced metastatic disease ( Stage IIIA , IIIB IV ) nonsquamous histology Patients must fail one prior chemotherapy regime must consider eligible chemotherapy follow progression disease . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 2 Adequate organ function Concurrent administration antitumor therapy Other coexist malignancy Pregnancy breast feed Serious concomitant disorder Inability unwillingness take folic acid vitamin B12 supplementation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>